One study utilizing human IL-26 transgenic (hIL-26Tg) mice and human cord blood mononuclear cells for modeling purposes found that IL-26 significantly increased neutrophil levels in both GVHD target tissues and peripheral blood. This evidence concerns the gene IL26 and graft versus host disease.